Sai Parenteral's Share Price
521.15+3.00 (+0.58%)
+28.46% past 1 Year
Sai Parenteral’s, along with its subsidiaries, carries out contract research and manufacturing activities for customers engaged in pharmaceutical industries. Its portfolio includes formulation products across various therapeutic areas like cardiovascular,
Corporate filings & documents
Announcements
Announcement under Regulation 30 (LODR)
1 week agoAnnouncement under Regulation 30 (LODR)
1 week agoAnnouncement under Regulation 30 (LODR)
1 week agoAnnouncement under Regulation 30 (LODR)
1 week agoIntimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August 2026
1 week agoIntimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August 2026
1 week agoNewspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.
2 weeks agoNewspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.
2 weeks agoSubmission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.
2 weeks agoSubmission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.
2 weeks agoBook closure intimation for 25th Annual General Meeting
2 weeks agoBook closure intimation for 25th Annual General Meeting
2 weeks agoAnnual Report of the company for FY 2025-26
2 weeks agoAnnual Report of the company for FY 2025-26
2 weeks agoNotice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September 2026.
2 weeks agoNotice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September 2026.
2 weeks agoTranscript of Earnings Call held on 12th August 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.
2 weeks agoTranscript of Earnings Call held on 12th August 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.
2 weeks agoAudio Recording of the Earnings call held on 12th August 2026
3 weeks agoAudio Recording of the Earnings call held on 12th August 2026
3 weeks agoInvestor Presentation Q1 FY 2027
3 weeks agoInvestor Presentation Q1 FY 2027
3 weeks agoPress Release
3 weeks agoPress Release
3 weeks agoStatement on deviation or varition of funds
3 weeks agoStatement on deviation or varition of funds
3 weeks agoAnnouncement under Regulation 30 (LODR)- Change in Management
3 weeks agoAnnouncement under Regulation 30 (LODR)- Change in Management
3 weeks agoUnaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.
3 weeks agoUnaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.
3 weeks agoOutcome of Board Meeting held on 11th August 2026 at the registered office of the company.
3 weeks agoOutcome of Board Meeting held on 11th August 2026 at the registered office of the company.
3 weeks agoThe Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August 2026.
3 weeks agoThe Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August 2026.
3 weeks agoSai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026.3. Any other business with the permission of the Chair.
1 month agoSai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026.3. Any other business with the permission of the Chair.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
1 month agoOutcome of Board Meeting
1 month agoOutcome of Board Meeting
1 month agoOutcome of the Board Meeting
1 month agoOutcome of the Board Meeting
1 month agoPress Release
2 months agoPress Release
2 months agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 months agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 months agoAnnouncement under Regulation 30 (LODR)
2 months agoAnnouncement under Regulation 30 (LODR)
2 months agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 months agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 months agoAnnual reports
No annual reports found
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Plot No.39, 5th Floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K. V Seri Lingampally Rangareddy Telangana PIN: 500032 Tel No: 7997991306 Fax No: NULL Email: [email protected] / [email protected] Internet: www.saiparenterals.com
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Anil Kumar Karusala, Managing Director
Vijitha Gorrepati, Whole Time Director
Seeta Ram Anjaneyulu Gorantla, Non Executive Independent Director
Bhagyashri Dharmasa Zad, Non Executive Independent Director
Shivali Aggarwal, Company Secretary & Compliance Officer
Kalidindi V Raju, Non Executive Independent Director
Kunal Kakumanu, Executive Director
Details
BSE 544742
NSE SAIPARENT
ISIN INE0H9F01037